Anticancer activity of Tea Tree Oil

University of Western Australia

  • Project code: PRJ-005829

  • Project stage: Closed

  • Project start date: Thursday, September 30, 2010

  • Project completion date: Tuesday, November 30, 2010

  • National Priority: TTO-Increasing demand


The reason for travel to the international terpene conference in Istanbul is to present our recently published paper “Inhibition of established subcutaneous murine tumour growth with topical Melaleuca alternifolia (Tea tree) oil”.
My presentation has been accepted as an oral presentation at this conference specialising in terpene applications. Attending this conference will give me a unique opportunity to network with international experts on terpenes and establish research collaborations. As tea tree oil is abundant in terpenes, presentation of our work to terpene experts will be invaluable.


Tea Tree Oil

Research Organisation

University of Western Australia

Objective Summary

The work to be presented is a combination of results obtained from RIRDC projects PRJ-000009, PRJ-002395 and the current project PRJ-005131. Presentation of these data will not only encourage new directions for our project, it will also ensure excellent exposure of our paper, which will generate more interest in our research. This has the potential to attract more research personnel and students to join our group, which will ultimately lead to greater funding opportunities and publications in very high quality journals. The presentation of the tea tree oil research funded by RIRDC, by myself and also by Ass/Prof Kate Hammer will significantly further enhnace the profile of this mainly Australian product and will further promote use of this natural, renewable resource. All benefits gained from this travel will be passed on to RIRDC and Novasel, our industry support by way of writing a detailed report.